Literature DB >> 17308841

Cryptococcus meningitis and reversible hearing loss.

Janini Oliveira Matos1, Andréia Migueres Arruda, Shiro Tomita, Patricia de Pinho Marques Araujo, Felipe Barbosa Madeira, Krishnamurti Matos de Araujo Sarmento Junior.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17308841      PMCID: PMC9442089          DOI: 10.1016/s1808-8694(15)31055-7

Source DB:  PubMed          Journal:  Braz J Otorhinolaryngol        ISSN: 1808-8686


× No keyword cloud information.

INTRODUCTION

Cryptococcosis is the most common fungal infection to strike the Central Nervous System. Its sub-acute manifestation includes fever, headache, nausea, and changes in behavior. Dysacousia takes place in up to 27% of patients, almost always bilaterally and suddenly. Reversibility is rare and was described by Mayer et al. in 1990. In general terms, if no treatment is offered death is the ultimate consequence.

CASE STUDY

AJGG, female, 29 years of age, arrived in our center on December 25, 2003 with intense headache, discomfort, nausea, diplopia and reduced visual acuity; the symptoms had begun manifesting themselves two months before. Her neck was stiff and the right abducens paretic. CBC came back normal and the quick HIV test was negative. Latex test, nankin dye and LCR indicated Cryptococcosis. CT scan revealed cerebral edema. The patient evolved to hypoacousia and then quickly to blindness and bilateral total hearing loss. The otolaryngological evaluation was normal, except for the paretic abducens. The patient’s condition made it impossible for audiometric tests to be conducted. BERA had thresholds at 110 dBSPL to the right and 100 dBSPL to the left, compatible with severe bilateral hearing loss for clicks. It was not possible to collect duplicated responses at 130 dBNPL and thus waves I, III and V were not analyzed. Otoacoustic emissions were normal. Treatment was initiated with intravenous Amphotericin B 50mg/day, getting to a dose of 1725 mg. The patient required a number of relief spinal taps and a ventriculoperitoneal shunt. After 100 days in the hospital the patient improved clinically and was discharged without headache and neck stiffness, with partially recovered auditory acuity (picture) and multiple negative LCR cultures for fungi.

DISCUSSION

Cryptococcal meningitis may occur at any given age and is more prevalent in immunologically compromised patients . Hypoacousia is described in as many as 27% of patients and may fluctuate, with losses ranging from moderate unilateral to severe bilateral. The mechanism leading to lesions in the auditory system has been studied. Igarashi et al. and Kwartler et al. have seen destruction of cochlear and vestibular structures, with the presence of microorganisms in the vestibulocochlear nerve, internal auditory meatus and cochlear structures. Harada et al. have seen most of these alterations, however with normal Corti’s organ and preserved vestibular nerve in relation to the cochlear nerve. Therefore, despite the apparent disagreement as to the involvement of the cochlea, all authors concur that there is retrocochlear damage. In this sense, normal otoacoustic emissions suggest preservation of the Corti’s organ. Mayer et al. described Hypoacousia reversibility in 19908. The mechanism is however not fully comprehended. Treatment of HIV-negative patients is done with amphotericin B and/or flucytosine for 6-10 weeks. This is a severe, potentially deadly disease.

CONCLUSIONS

Cryptococcal meningitis is a severe infection and its clinical signs are of difficult diagnosis. Auditory involvement seems frequent, and its reversibility, rare. Early treatment is therefore of utmost importance, as is audiometric monitoring in the cases being followed.
  6 in total

1.  Temporal bone findings in cryptococcal meningitis.

Authors:  M Igarashi; S C Weber; B R Alford; A C Coats; J Jerger
Journal:  Arch Otolaryngol       Date:  1975-09

2.  Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.

Authors:  M S Saag; R J Graybill; R A Larsen; P G Pappas; J R Perfect; W G Powderly; J D Sobel; W E Dismukes
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

3.  Cryptococcal meningitis: implications for the otologist.

Authors:  W K Low
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2002 Jan-Feb       Impact factor: 1.538

4.  Vestibular dysfunction due to cryptococcal meningitis.

Authors:  K V Hughes; J D Green; S Alvarez; R Reimer
Journal:  Otolaryngol Head Neck Surg       Date:  1997-04       Impact factor: 5.591

5.  Temporal bone histopathology in deafness due to cryptococcal meningitis.

Authors:  T Harada; I Sando; E N Myers
Journal:  Ann Otol Rhinol Laryngol       Date:  1979 Sep-Oct       Impact factor: 1.547

6.  Sudden hearing loss due to AIDS-related cryptococcal meningitis--a temporal bone study.

Authors:  J A Kwartler; F H Linthicum; A F Jahn; M Hawke
Journal:  Otolaryngol Head Neck Surg       Date:  1991-02       Impact factor: 3.497

  6 in total
  1 in total

1.  Audiologic and Otologic Complications of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Patients.

Authors:  Kelly A King; Ghedak Ansari; Anil A Panackal; Chris Zalewski; Seher Anjum; John E Bennett; Andrea Beri; Hung Jeff Kim; Dima Hammoud; Carmen C Brewer; Peter R Williamson
Journal:  Otol Neurotol       Date:  2019-07       Impact factor: 2.619

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.